FDA: Don’t use certain SD Biosensor COVID-19 tests

Consumers and health care providers should not use certain SD Biosensor Pilot COVID-19 At-Home Tests distributed by Roche Diagnostics due to bacterial contamination, but throw them in the trash, the Food and Drug Administration announced last week. Health care providers should consider retesting patients using the test less than two weeks ago if they suspect an inaccurate result; consider whether patients presenting with signs of bacterial infection recently used the test; and report any problems experienced with the tests to the MedWatch program, FDA said.
Related News Articles
Headline
The Food and Drug Administration’s independent Nonprescription Drugs Advisory Committee Sept. 12 by unanimous vote declared oral phenylephrine…
Headline
The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333),…
Headline
The Food and Drug Administration’s vaccine advisory committee June 15 voted unanimously to recommend updating the current COVID-19 vaccine composition for…
Headline
The first data on the safety of a third mRNA COVID-19 vaccine dose among young children show that a third dose is safe for children ages 6 months to 5 years…
Headline
The Food and Drug Administration authorized for marketing the first at-home over-the-counter test for COVID-19 using a traditional premarket review…
Headline
The Centers for Medicare & Medicaid Services May 31 released regulatory changes to the COVID-19 health care staff vaccination requirements and long-term…